Advertisement
U.S. markets open in 40 minutes

UroGen Pharma Ltd. (URGN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
14.96-0.21 (-1.38%)
At close: 04:00PM EDT
14.96 0.00 (0.00%)
After hours: 04:20PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close15.17
Open15.59
Bid14.86 x 100
Ask14.99 x 100
Day's Range14.45 - 15.59
52 Week Range8.26 - 24.13
Volume248,861
Avg. Volume347,844
Market Cap510.467M
Beta (5Y Monthly)1.10
PE Ratio (TTM)N/A
EPS (TTM)-3.55
Earnings DateMay 09, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est38.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for URGN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • UroGen Pharma Ltd.
    Daily – Vickers Top Buyers & Sellers for 01/10/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 years agoArgus Research
View more